Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Personalised Cancer Medicine Guide for Patients


Personalised medicine is the future of cancer medicine. To make it a reality in the near future and to offer improved treatments, the patient’s active role is crucial.

ESMO is committed to educating patients in this evolving approach, so they can better understand the main principles and how they can contribute. Well-informed patients and educated choices matter.

Personalised cancer medicine guide for patients

The goal of this guide is not to present the personalised medicine achievements in every tumour type or to elaborate on situations where it is not yet a part of standard practice. Instead, in this material we provided an overview on governing principles, illustrating them through examples of personalised medicine approaches in several tumour types.

Download the Guide

In this guide you can find information on:

  • What is personalised medicine?
  • Personalisation of oncological treatments
  • The new era: discovery of DNA
  • Understand how to personalise each individual treatment
  • Understand how to personalise disease
  • Why is it important for cancer patients to understand personalised medicine?
  • Personalisation of healthy living
  • Glossary of terms

Personalised Medicine Factsheet

The ESMO Guide for Patients in personalised cancer medicine is now complemented by a factsheet.

Download the Factsheet

The factsheet discusses:

  • the definition of personalised medicine
  • evidence in cancer biology
  • targeted therapy explanations
  • what patients should be aware of
  • challenges that need to be solved
  • the need for education & research

This guide for patients has been initiated by the ESMO Personalised Medicine Task Force as part of the ESMO strategic activities to assist patients, their family members and friends to better understand the factors that may influence the personalised approach to the prevention, diagnosis and treatment of cancer.

Representatives from European cancer patient advocacy groups and members of the ESMO Cancer Patient Working Group also provided their views and comments on different issues in personalised cancer medicine.

Published in 2013

To enquire about permission to translate or support the distribution (in English or in a translated version) of the Patient Guides series, please send an e-mail to patient_guides@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.